HeartBeam, Inc. (BEAT) vs Renalytix plc - Sponsored ADR (RNLXY)
- HeartBeam, Inc. BEAT 0.40 +2.56%
- Renalytix plc - Sponsored ADR RNLXY 3.70 −2.37%
HeartBeam, Inc. and Renalytix plc - Sponsored ADR are both Health Information Services companies. HeartBeam, Inc. is the larger, with a market value of $22.2M against $17.2M — 1.3× the size. HeartBeam, Inc. has the higher net margin (0.00% vs −1,186.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, HeartBeam, Inc. leads on 5 and Renalytix plc - Sponsored ADR on 5.
Valuation
Profitability
| Metric | BEAT | RNLXY | Health Information Services median |
|---|---|---|---|
| Gross margin | — | 14.52% | 59.61% |
| Operating margin | 0.00% | (1,087.73%) | (10.54%) |
| Net margin | 0.00% | (1,186.20%) | (16.14%) |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (328.44%) | 0.00% | (3.15%) |
| Return on assets | (244.27%) | 0.00% | (5.62%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack